EASL Congress | Pedestal Health

7

Total Publications

1

Oral Presentation

6

Poster Presentation

2025 · Poster Presentation · Poster Presentation · Hepatology

Real world treatment patterns and outcomes for hepatocellular carcinoma (HCC) patients receiving transarterial chemoembolization (TACE) or transarterial radioembolization (TARE) in the TARGET-HCC registry.

2024 · Poster Presentation · Poster Presentation · Hepatology

Type 2 diabetes increases the risk of progression to metabolic dysfunction-associated steatohepatitis-related cirrhosis in a real world setting.

2024 · Poster Presentation · Poster Presentation · Hepatology

Real-World Use of Glucagon-Like Peptide 1 Receptor Agonists in Patients with MASLD: A Cross-Sectional Analysis from TARGET-NASH.

2024 · Poster Presentation · Poster Presentation · Hepatology

A prospective assessment of disease progression impact on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease.

2023 · Poster Presentation · Poster Presentation · Hepatology

A Prospective, Pragmatic Post-Authorisation Safety Study of Early Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients after Direct-Acting Antiviral (DAA) Therapy: DAA-PASS.

2023 · Oral Presentation · Oral Presentation · Hepatology

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study.

2022 · Poster Presentation · Poster Presentation · Hepatology

Longitudinal ALT Trajectories are Generally Stable Among Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): An Investigation Using Artificial Recurrent Neural Networks.